From 3967.97$

polatuzumab vedotin

Miscellaneous antineoplastics

Scoring is done by our AI based assistant on the data from the FDA and other sources

5.6

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

4.5

Isotretinoin

4.2

Tisotumab vedotin-tftv (Intravenous)

4.2

Sacituzumab govitecan-hziy (Intravenous)

4.1

Lenalidomide

4.1

Polatuzumab vedotin-piiq (Intravenous)

4.1

Talimogene laherparepvec

4.1

Mogamulizumab-kpkc (Intravenous)

4.1

Matulane

4.1

Olaratumab (Intravenous)